Vedolizumab for the treatment of IBD: a selective therapeutic approach targeting pathogenic a4b7 cells.

Manol Jovani, Silvio Danese

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Vedolizumab for the treatment of IBD: a selective therapeutic approach targeting pathogenic a4b7 cells.'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds